share_log

We Think Winning Health Technology Group (SZSE:300253) Can Stay On Top Of Its Debt

We Think Winning Health Technology Group (SZSE:300253) Can Stay On Top Of Its Debt

我们认为 Winning Health Technology Group(深圳证券交易所代码:300253)可以继续偿还债务
Simply Wall St ·  05/13 22:01

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. We note that Winning Health Technology Group Co., Ltd. (SZSE:300253) does have debt on its balance sheet. But should shareholders be worried about its use of debt?

传奇基金经理李露(由查理·芒格支持)曾经说过:“最大的投资风险不是价格的波动,而是你是否会遭受永久的资本损失。”因此,很明显,当你考虑任何给定股票的风险时,你需要考虑债务,因为过多的债务会使公司陷入困境。我们注意到,威宁健康科技集团有限公司(深圳证券交易所代码:300253)的资产负债表上确实有债务。但是,股东是否应该担心其债务的使用?

Why Does Debt Bring Risk?

为什么债务会带来风险?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

一般而言,只有当公司无法通过筹集资金或用自己的现金流轻松还清债务时,债务才会成为真正的问题。如果情况变得非常糟糕,贷款人可以控制业务。但是,更常见(但仍然昂贵)的情况是,公司为了控制债务,必须以低廉的股价稀释股东。话虽如此,最常见的情况是公司合理地管理债务,而且对自己有利。在考虑企业使用多少债务时,要做的第一件事是同时考虑其现金和债务。

What Is Winning Health Technology Group's Net Debt?

华宁健康科技集团的净负债是多少?

You can click the graphic below for the historical numbers, but it shows that as of March 2024 Winning Health Technology Group had CN¥1.05b of debt, an increase on CN¥995.8m, over one year. However, it does have CN¥973.1m in cash offsetting this, leading to net debt of about CN¥75.1m.

你可以点击下图查看历史数字,但它显示,截至2024年3月,Winning Health Technology Group在一年内有10.5亿元人民币的债务,比9.9958亿元人民币的债务有所增加。但是,它确实有9.731亿元的现金抵消了这一点,净负债约为7,510万加元。

debt-equity-history-analysis
SZSE:300253 Debt to Equity History May 14th 2024
SZSE: 300253 2024 年 5 月 14 日债务与股本比率的历史记录

How Strong Is Winning Health Technology Group's Balance Sheet?

威宁健康科技集团的资产负债表有多强?

The latest balance sheet data shows that Winning Health Technology Group had liabilities of CN¥1.56b due within a year, and liabilities of CN¥1.16b falling due after that. Offsetting this, it had CN¥973.1m in cash and CN¥3.53b in receivables that were due within 12 months. So it can boast CN¥1.78b more liquid assets than total liabilities.

最新的资产负债表数据显示,Winning Health Technology Group的负债为15.6亿元人民币,之后到期的负债为11.6亿元人民币。与此相抵消的是,它有9.731亿元的现金和35.3亿元人民币的应收账款将在12个月内到期。因此,它拥有的流动资产可以多出17.8亿元人民币 负债。

This surplus suggests that Winning Health Technology Group has a conservative balance sheet, and could probably eliminate its debt without much difficulty. Carrying virtually no net debt, Winning Health Technology Group has a very light debt load indeed.

这种盈余表明,Winning Health Technology Group的资产负债表比较保守,可以毫不费力地消除债务。Winning Health Technology Group几乎没有净负债,债务负担确实很轻。

In order to size up a company's debt relative to its earnings, we calculate its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and its earnings before interest and tax (EBIT) divided by its interest expense (its interest cover). This way, we consider both the absolute quantum of the debt, as well as the interest rates paid on it.

为了扩大公司相对于收益的负债规模,我们计算其净负债除以利息、税项、折旧和摊销前的收益(EBITDA),将其利息和税前收益(EBIT)除以利息支出(利息保障)。这样,我们既考虑债务的绝对数量,也考虑为债务支付的利率。

Winning Health Technology Group has a low net debt to EBITDA ratio of only 0.19. And its EBIT covers its interest expense a whopping 16.6 times over. So we're pretty relaxed about its super-conservative use of debt. It was also good to see that despite losing money on the EBIT line last year, Winning Health Technology Group turned things around in the last 12 months, delivering and EBIT of CN¥373m. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately the future profitability of the business will decide if Winning Health Technology Group can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

威宁健康科技集团的净负债与息税折旧摊销前利润的比率很低,仅为0.19。其息税前利润可支付其高达16.6倍的利息支出。因此,我们对它超保守的债务使用相当放松。同样令人高兴的是,尽管去年息税前利润出现亏损,但Winning Health Technology Group在过去12个月中扭转了局面,实现了3.73亿元人民币的息税前利润。在分析债务水平时,资产负债表是显而易见的起点。但最终,该业务未来的盈利能力将决定Winning Health Technology Group能否随着时间的推移加强其资产负债表。因此,如果您专注于未来,可以查看这份显示分析师利润预测的免费报告。

But our final consideration is also important, because a company cannot pay debt with paper profits; it needs cold hard cash. So it is important to check how much of its earnings before interest and tax (EBIT) converts to actual free cash flow. During the last year, Winning Health Technology Group burned a lot of cash. While investors are no doubt expecting a reversal of that situation in due course, it clearly does mean its use of debt is more risky.

但是我们最终的考虑因素也很重要,因为公司无法用纸面利润来偿还债务;它需要冷硬现金。因此,重要的是要检查其利息和税前收益(EBIT)中有多少可以转换为实际的自由现金流。去年,Winning Health Technology Group烧掉了大量现金。尽管投资者无疑预计这种情况将在适当的时候逆转,但这显然意味着其使用债务的风险更大。

Our View

我们的观点

Happily, Winning Health Technology Group's impressive interest cover implies it has the upper hand on its debt. But the stark truth is that we are concerned by its conversion of EBIT to free cash flow. It's also worth noting that Winning Health Technology Group is in the Healthcare Services industry, which is often considered to be quite defensive. All these things considered, it appears that Winning Health Technology Group can comfortably handle its current debt levels. On the plus side, this leverage can boost shareholder returns, but the potential downside is more risk of loss, so it's worth monitoring the balance sheet. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. Case in point: We've spotted 1 warning sign for Winning Health Technology Group you should be aware of.

令人高兴的是,Winning Health Technology Group令人印象深刻的利息保障意味着其债务占上风。但严峻的事实是,我们对其将息税前利润转换为自由现金流感到担忧。还值得注意的是,Winning Health Technology Group属于医疗保健服务行业,该行业通常被认为具有很强的防御性。考虑到所有这些因素,Winning Health Technology Group似乎可以轻松应对其目前的债务水平。从好的方面来看,这种杠杆作用可以提高股东的回报,但潜在的缺点是损失风险更大,因此值得关注资产负债表。在分析债务水平时,资产负债表是显而易见的起点。但归根结底,每家公司都可以控制资产负债表之外存在的风险。一个很好的例子:我们已经发现了Winning Health Technology Group的1个警告信号,你应该注意。

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

当一切都说完之后,有时更容易将注意力集中在甚至不需要债务的公司上。读者现在可以100%免费访问净负债为零的成长型股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发